Advanced BioDesign

Overcoming Tumor Drug Resistance

[Advanced BioDesign @ABioDesign]

ABD's work has been selected by the scientific committee for an ORAL presentation at #EACR2023 congress in Turin, Italy. https://t.co/b0SVfexg6A

[Advanced BioDesign @ABioDesign]

I am very happy to announce our participation in the #EHA2023 from June 8-11 in Frankfurt where we will be represented by Mileidys Perez (CSO). Through a poster entitled “ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA". EHA Library. Shaikh M. 06/08/2023; 386279; P450

[ENHPATHY @enhpathy_H2020]

📣 Happening today!
Half-time retreat Day#4 with Mileidys Perez - @ABioDesign Aude Veinante Gardey - @LAVOIX_IP Joris van Arensbergen @JArensbergen - Annogen B.V. Koen Verhoef @NKI_nl and Carlo Chiavaroli - @VCLSsocial
@MSCActions

[Advanced BioDesign @ABioDesign]

Today is Triple-Negative Breast Cancer (#TNBC) Day. @ABioDesign, we are committed to fight against this aggressive cancer with its promising approach using #ALDHinhibitors.
#cancer #tumorresistance

[Advanced BioDesign @ABioDesign]

@ABioDesign receives the authorization from the French autohorities for its "First-In-Human" clinical trial "#ODYSSEY"
https://t.co/fVTlQUm18m

[Advanced BioDesign @ABioDesign]

Initiate in 2020, our collaboration with the TIME team and Dr Bassam Janji is evolving into a new dimension with the “TRICK-ALDH” project. This collaboration will accelerate the launch of our innovative approach for the benefit of patients.
https://t.co/SV7ODYjt8z

[Advanced BioDesign @ABioDesign]

@Advanced BioDesign is committed against breast cancer!
The team is mobilizing against resistant cancers with its promising approach and its research programs on #TNBC, which represent 15% of breast cancer.
#pinkoctober, #cancerresistance

[Advanced BioDesign @ABioDesign]

We are #hiring a #postdoctoral position #postdocjobs. 💼

Do you know someone who might be interested?👀

If you fulfill the eligibility criteria and provide the above requirements, send your application.

https://t.co/7spoKp2R24

[Advanced BioDesign @ABioDesign]

@UABBarcelona, in collaboration @ABioDesign presents first preclinical evidence of the antitumour effect of DIMATE against #glioblastoma at @43congresoSEBBM .
#cancerresistance

[ENHPATHY @enhpathy_H2020]

Interested in #enhancers and their role in human disease? Join the @EMBO workshop co-organized by @IglesiadRada @S_Spicuglia @susmandrup
Registration 👉 https://t.co/0rwbrByvnG
Registr. deadline 👉27 August 2021
Abstract submission deadline 👉27 August 2021
#EMBOenhanceropathies

[Francesco Leonetti @Fran__Leonetti]

Here my first post for "All Eyes On Enhancers" #AEOE blog by @enhpathy_H2020 about my PhD project.
@ABioDesign @MSCActions #enhanceropathies

https://t.co/mkgjceBHmM

[Advanced BioDesign @ABioDesign]

Today is #TNBCDay. At @ABioDesign we're working on the development of a new approach for resistant cancer like #tnbc with our program THERALDIN®TNBC. #oncology #tumorresistance
https://t.co/x7rK7nX48W

[Institut national du cancer @Institut_cancer]

#JournéeInternationaleDuCancerDeLenfant « Se mobiliser pour faire reculer les cancers de l’enfant, de l’adolescent et du jeune adulte » est l’une des actions clés de la nouvelle #stratégieCancers, figurant dans la feuille de route 2021-2025. En savoir plus https://t.co/VM07wnnd46

[Advanced BioDesign @ABioDesign]

Despite breakthroughs treatments in #BreastCancer, the disease continues to affect millions of people. #TNBC (15% of #BreastCancer) have aggressive behaviour and lack of therapies. @ABioDesign is committed to create alternative for #TNBC. #pinktober
https://t.co/5Zq5O2o4DQ

[Advanced BioDesign @ABioDesign]

@ABioDesign and Dr @bassam_janji and his team TIME (Tumor Immunotherapy and Microenvironment) from @LIH_Luxembourg will collaborate on tumour resistance.
https://t.co/c5njDhS30Z
#oncology #precisionmedecine #tumorresistance

[Advanced BioDesign @ABioDesign]

🎙 @ceylan_abd sur @Biotech_finance en partenariat avec @FranceBiotech pour évoquer le développement d'@ABioDesign
https://t.co/7ubwn6xDop

[Advanced BioDesign @ABioDesign]

Platinum-based chemotherapy resistance is a major hurdle limiting treatment success in NSCLC. Recently, @ABioDesign publish in @oncogenejournal a real alternative to overcome this problem #targetedtherapy #precisionmedicine #lungcancer #oncology
https://t.co/gno5B6PGlJ

[ENHPATHY @enhpathy_H2020]

Today's the last day to apply for the @enhpathy_H2020 PhD program from ITN @MSCActions. Ambitious international students who want to work on function and mechanisms of transcriptional enhancers in human diseases, apply here: https://t.co/p6xdaoPsdl

[Advanced BioDesign @ABioDesign]

PhD Projects call are still open. Submit your application.
Apply here https://t.co/XMksGOi2l5
@MSCActions @enhpathy_H2020

[ENHPATHY @enhpathy_H2020]

OPEN CALL 15 PhD PROJECTS - Submit your application today! Apply here 👉 https://t.co/vINdKsaXPn
@MSCActions @Mariecurie_alum @YERUN_EU @Eurodoc